Register entry
- Registered sites
- 0
- Active NDC listings
- 1
- Live patents
- 0
- Countries
- 0
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| RAPIBLYK | landiolol | injection, powder, lyophilized, for solution, intravenous | 84381-110NDA |
Enquiry
Common questions
- Is AOP Orphan Pharmaceuticals GmbH FDA approved?
- AOP Orphan Pharmaceuticals GmbH holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does AOP Orphan Pharmaceuticals GmbH make?
- 1 product is listed under AOP Orphan Pharmaceuticals GmbH in the openFDA NDC Directory, most often as injection, powder, lyophilized, for solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.